- Home
- FENC vs LANV Comparison
FENC vs LANV Comparison
Compare FENC & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- LANV
- Stock Information
- Founded
- FENC 1996
- LANV 2015
- Country
- FENC United States
- LANV China
- Employees
- FENC N/A
- LANV N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- LANV Blank Checks
- Sector
- FENC Health Care
- LANV Finance
- Exchange
- FENC Nasdaq
- LANV Nasdaq
- Market Cap
- FENC 181.7M
- LANV 196.8M
- IPO Year
- FENC 2001
- LANV N/A
- Fundamental
- Price
- FENC $3.99
- LANV $1.70
- Analyst Decision
- FENC Strong Buy
- LANV
- Analyst Count
- FENC 2
- LANV 0
- Target Price
- FENC $14.00
- LANV N/A
- AVG Volume (30 Days)
- FENC 116.0K
- LANV 18.8K
- Earning Date
- FENC 11-07-2024
- LANV 08-26-2024
- Dividend Yield
- FENC N/A
- LANV N/A
- EPS Growth
- FENC N/A
- LANV N/A
- EPS
- FENC N/A
- LANV N/A
- Revenue
- FENC $49,348,000.00
- LANV $409,961,427.00
- Revenue This Year
- FENC $116.50
- LANV N/A
- Revenue Next Year
- FENC $17.49
- LANV $11.31
- P/E Ratio
- FENC N/A
- LANV N/A
- Revenue Growth
- FENC 278.09
- LANV N/A
- 52 Week Low
- FENC $3.97
- LANV $0.91
- 52 Week High
- FENC $11.92
- LANV $4.24
- Technical
- Relative Strength Index (RSI)
- FENC 38.47
- LANV 51.85
- Support Level
- FENC $3.99
- LANV $1.42
- Resistance Level
- FENC $4.57
- LANV $1.80
- Average True Range (ATR)
- FENC 0.31
- LANV 0.15
- MACD
- FENC -0.02
- LANV -0.01
- Stochastic Oscillator
- FENC 2.33
- LANV 76.82
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.